| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jan―09 |
Cover Feature: Structural Characterization and AI-Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS-CoV-2 Variants (Adv. Therap. 1/2026) |
Katja Hanack, Urszula Orzeł, Anja Schlör, Sourabh Mehta, Anandi Krishnan, Slawomir Filipek, Rushika Patel, Madhvi Joshi, Markus Hoffmann, Stefan Pöhlmann, Chaitanya Joshi, Dorian Liepmann, Ramasamy Paulmurugan, Venkatesan Renugopalakrishnan |
| 2 |
[GO] |
2025―Oct―21 |
Structural Characterization and AI-Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS-CoV-2 Variants |
Katja Hanack, Urszula Orzeł, Anja Schlör, Sourabh Mehta, Anandi Krishnan, Slawomir Filipek, Rushika Patel, Madhvi Joshi, Markus Hoffmann, Stefan Pöhlmann, Chaitanya Joshi, Dorian Liepmann, Ramasamy Paulmurugan, Venkatesan Renugopalakrishnan |
| 3 |
[GO] |
2025―Jun―18 |
Mimicking Biochemical Traits with a Synthetic Lipid Nanoparticles SARS-COV-2 Model (Adv. Therap. 6/2025) |
Ignasia Handipta Mahardika, Hyun Park, Eunjin Huh, Changyoon Baek, Shin-Gyu Cho, Kwang-Hwan Jung, Junhong Min, Kwanwoo Shin |
| 4 |
[GO] |
2025―Apr―28 |
Mimicking Biochemical Traits with a Synthetic Lipid Nanoparticles SARS-COV-2 Model |
Ignasia Handipta Mahardika, Hyun Park, Eunjin Huh, Changyoon Baek, Shin-Gyu Cho, Kwang-Hwan Jung, Junhong Min, Kwanwoo Shin |
| 5 |
[GO] |
2022―Sep―12 |
Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-blind, Placebo-Controlled Trial |
C R Jayanthi, Ashok K Swain, Ranganath T Ganga, Dnyaneshwar Halnor, Ajit Avhad, Saif Khan, Ayan Ghosh, Sumer Sanjiv Choudhary, Anand Namdevrao Yannawar, Shubhangi Despande, Manish Patel, Krishna Prasad Anne, Yogesh Bangar |
| 6 |
[GO] |
2021―Oct―21 |
Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach |
Vincent K. C. Yan, Xiaodong Li, Xuxiao Ye, Min Ou, Ruibang Luo, Qingpeng Zhang, Bo Tang, Benjamin J. Cowling, Ivan Hung, Chung Wah Siu, Ian C. K. Wong, Reynold C. K. Cheng, Esther W. Chan |
| 7 |
[GO] |
2021―Aug―06 |
Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV |
Disha Panchal, Jeena Kataria, Kamiya Patel, Kaytlyn Crowe, Varun Pai, Abdul-Rahman Azizogli, Neil Kadian, Sreya Sanyal, Abhishek Roy, Joseph Dodd-o, Amanda M. Acevedo-Jake, Vivek A. Kumar |
| 8 |
[GO] |
2021―Aug―02 |
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants |
Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Emily K. Makowski, Matthew D. Smith, Ghasidit Pornnoppadol, Mayara Garcia de Mattos Barbosa, Marilia Cascalho, Thomas M. Lanigan, Peter M. Tessier |
| 9 |
[GO] |
2021―Jul―20 |
Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity (Adv. Therap. 7/2021) |
Pratik Adhikary, Sashi Kandel, Umar-Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien-Yu Lin, Evanthia Omoscharka, Kun Cheng |
| 10 |
[GO] |
2021―Jun―11 |
Inhaled Dry Powder Formulation of Tamibarotene, a Broad-Spectrum Antiviral against Respiratory Viruses Including SARS-CoV-2 and Influenza Virus |
Qiuying Liao, Shuofeng Yuan, Jianli Cao, Kaiming Tang, Yingshan Qiu, Han Cong Seow, Rico Chi-Hang Man, Zitong Shao, Yaoqiang Huang, Ronghui Liang, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Jenny Ka-Wing Lam |
| 11 |
[GO] |
2021―May―20 |
Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach |
Vincent K. C. Yan, Xiaodong Li, Xuxiao Ye, Min Ou, Ruibang Luo, Qingpeng Zhang, Bo Tang, Benjamin J. Cowling, Ivan Hung, Chung Wah Siu, Ian C. K. Wong, Reynold C. K. Cheng, Esther W. Chan |
| 12 |
[GO] |
2021―May―17 |
Promising Immunotherapies against COVID-19 |
Haodong Guo, Lili Zhou, Zhenyu Ma, Zhixin Tian, Fangfang Zhou |
| 13 |
[GO] |
2021―Apr―26 |
Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity |
Pratik Adhikary, Sashi Kandel, Umar-Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien-Yu Lin, Evanthia Omoscharka, Kun Cheng |
| 14 |
[GO] |
2021―Feb―22 |
Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion |
Chan Yang, Xiaoyan Pan, Yuan Huang, Chen Cheng, Xinfeng Xu, Yan Wu, Yunxia Xu, Weijuan Shang, Xiaoge Niu, Yihong Wan, Zhaofeng Li, Rong Zhang, Shuwen Liu, Gengfu Xiao, Wei Xu |
| 15 |
[GO] |
2021―Feb―14 |
Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2 |
Lauren Wells, Cory Vierra, Janee’ Hardman, Yanxiao Han, Dustin Dimas, Lucia N. Gwarada-Phillips, Rachel Blackeye, Daryl K. Eggers, Celia C. LaBranche, Petr Král, Katherine D. McReynolds |
| 16 |
[GO] |
2020―Dec―16 |
Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies |
Zhina Hadisi, Tavia Walsh, Seyed Mohammad Hossein Dabiri, Amir Seyfoori, David Hamdi, Bahram Mirani, Erik Pagan, Armando Jardim, Mohsen Akbari |
| 17 |
[GO] |
2020―Oct―26 |
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector |
Taru Dube, Amrito Ghosh, Jibanananda Mishra, Uday B. Kompella, Jiban Jyoti Panda |
| 18 |
[GO] |
2020―Oct―14 |
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus |
Joydeb Majumder, Tamara Minko |
|
